GLPG1205
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Lakefront Biotherapeutics NV
Overview
GLPG1205 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
GLPG1205 clinical trials
Explore related
Medical disclaimer. This page summarizes research about GLPG1205 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.